help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHULMAN, L. L.
Right arrow Articles by ITESCU, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHULMAN, L. L.
Right arrow Articles by ITESCU, S.

Am. J. Respir. Crit. Care Med., Volume 163, Number 2, February 2001, 437-442

Influence of Donor and Recipient HLA Locus Mismatching on Development of Obliterative Bronchiolitis after Lung Transplantation

LARRY L. SCHULMAN, ALAN D. WEINBERG, CARLTON C. McGREGOR, NICOLE M. SUCIU-FOCA, and SILVIU ITESCU

Departments of Medicine, Pathology, and Surgery, College of Physicians and Surgeons, Columbia University, New York, New York

Obliterative bronchiolitis (OB) after lung transplantation is the end result of multiple immunologic, virologic, genetic, and environmental effects on the transplanted lung. In this study, we first analyzed risk factors for OB in a single-center population of 152 lung transplant recipients. We then examined the influence of donor and recipient HLA mismatching on progression to OB, and on the identified risk factors for OB. The median time to onset of OB for the entire study population was 2.7 yr. The significant risk factors for OB by multivariate analyses were grade A2 or A3 acute rejection (p = 0.0126) and cytomegalovirus (CMV) pneumonitis (p = 0.0358). The only significant HLA risk factor for OB was mismatching at the HLA-A locus (p = 0.0144). On the basis of Cox proportional hazards modeling, a predictive formula was derived to estimate the risk of OB after lung transplantation. Although mismatching at the HLA-DR locus was a significant risk factor for CMV pneumonitis in recipients exposed to CMV before transplantation (p = 0.0199), and protected against acute rejection, it did not independently protect against OB. These results indicate that HLA mismatches between donors and recipients significantly influence the development of OB both directly, and indirectly, by influencing the major risk factors for OB.




This article has been cited by other articles:


Home page
 JAMAHome page
K. M. Williams, J. W. Chien, M. T. Gladwin, and S. Z. Pavletic
Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
JAMA, July 15, 2009; 302(3): 306 - 314.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
L. P. Nicod
Mechanisms of airway obliteration after lung transplantation.
Proceedings of the ATS, July 1, 2006; 3(5): 444 - 449.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. M. Hopkins, C. L. Aboyoun, P. N. Chhajed, M. A. Malouf, M. L. Plit, S. P. Rainer, and A. R. Glanville
Association of Minimal Rejection in Lung Transplant Recipients with Obliterative Bronchiolitis
Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 1022 - 1026.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Boehler and M. Estenne
Post-transplant bronchiolitis obliterans
Eur. Respir. J., December 1, 2003; 22(6): 1007 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
W. Chalermskulrat, I. P. Neuringer, J. L. Schmitz, D. J. Catellier, M. J. Gurka, S. H. Randell, and R. M. Aris
Human Leukocyte Antigen Mismatches Predispose to the Severity of Bronchiolitis Obliterans Syndrome After Lung Transplantation
Chest, June 1, 2003; 123(6): 1825 - 1831.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. A. Johnson, A. T. Iacono, A. Zeevi, K. R. McCurry, and S. R. Duncan
Statin Use Is Associated with Improved Function and Survival of Lung Allografts
Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1271 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
W. Chalermskulrat, I. P. Neuringer, W. J. Brickey, N. J. Felix, S. H. Randell, J. P. Ting, and R. M. Aris
Hierarchical Contributions of Allorecognition Pathways in Chronic Lung Rejection
Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 999 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. A. Schnitzler, J. A. Lowell, S. P. Hmiel, K. L. Hardinger, H. Liapis, C. S. Ceriotti, and D. C. Brennan
Cytomegalovirus Disease after Prophylaxis with Oral Ganciclovir in Renal Transplantation: The Importance of HLA-DR Matching
J. Am. Soc. Nephrol., March 1, 2003; 14(3): 780 - 785.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Hadjiliadis, R. D. Davis, and S. M. Palmer
Is Transplant Operation Important in Determining Posttransplant Risk of Bronchiolitis Obliterans Syndrome in Lung Transplant Recipients?
Chest, October 1, 2002; 122(4): 1168 - 1175.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. Estenne and M. I. Hertz
Bronchiolitis Obliterans after Human Lung Transplantation
Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 440 - 444.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society